New nanoparticles aid sepsis treatment in mice

Sepsis, the body's overreaction to an infection, affects more than 1.5 million people and kills at least 270,000 every year in the U.S. alone. The standard treatment of antibiotics and fluids is not effective for many patients, and those who survive face a higher risk of death. Researchers have reported a new nanoparticle-based treatment that delivers anti-inflammatory molecules and antibiotics.